Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in Hematology and Oncology. Spectrum currently markets six hematology/oncology drugs, and has an advanced stage pipeline that has the potential to transform the company. Spectrum's expertise has generated a diversified, and growing pipeline of product candidates in advanced-stage Phase 2 and Phase 3 studies. More information at www.sppirx.com.